{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T22:46:12Z","timestamp":1725835572386},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1097\/inf.0b013e3180616ca5","type":"journal-article","created":{"date-parts":[[2007,6,21]],"date-time":"2007-06-21T08:03:11Z","timestamp":1182412991000},"page":"653-655","source":"Crossref","is-referenced-by-count":3,"title":["ACUTE HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN A BREAST-FED INFANT IN NEW YORK CITY"],"prefix":"10.1097","volume":"26","author":[{"given":"Ouzama","family":"Nicholson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Michalik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"LaRussa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Neu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-23-20210202","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.","volume":"331","author":"Connor","year":"1994","journal-title":"N Engl J Med"},{"key":"R2-23-20210202","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa033500","article-title":"Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.","volume":"351","author":"Lallemant","year":"2004","journal-title":"N Engl J Med"},{"key":"R3-23-20210202","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1001\/jama.285.16.2083","article-title":"Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.","volume":"285","author":"Mandelbrot","year":"2001","journal-title":"JAMA"},{"key":"R4-23-20210202","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/00042560-200204150-00009","article-title":"Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.","volume":"29","author":"Cooper","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R5-23-20210202","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1086\/427287","article-title":"Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy.","volume":"40","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R6-23-20210202","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00126334-200501010-00016","article-title":"Risk factors for in utero and intrapartum transmission of HIV.","volume":"38","author":"Magder","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R7-23-20210202","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/00126334-200408150-00011","article-title":"Decline in perinatal HIV transmission in New York State (1997\u20132000).","volume":"36","author":"Wade","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R8-23-20210202","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jama.285.6.709","article-title":"Understanding the timing of HIV transmission from mother to infant.","volume":"285","author":"Kourtis","year":"2001","journal-title":"JAMA"},{"key":"R9-23-20210202","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1001\/jama.283.9.1167","article-title":"Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial.","volume":"283","author":"Nduati","year":"2000","journal-title":"JAMA"},{"key":"R10-23-20210202","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(05)67481-8","article-title":"Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study.","volume":"366","author":"Gray","year":"2005","journal-title":"Lancet"},{"key":"R11-23-20210202","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00042560-199903010-00013","article-title":"Incidence and risk factors for heterosexually acquired HIV in an inner-city cohort of women: temporal association with pregnancy.","volume":"20","author":"Chirgwin","year":"1999","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R12-23-20210202","first-page":"1119","article-title":"ACOG committee opinion number 304, November 2004. Prenatal and perinatal human immunodeficiency virus testing: expanded recommendations.","volume":"104","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R13-23-20210202","first-page":"782","article-title":"Human immunodeficiency virus retesting during pregnancy: costs and effectiveness in preventing perinatal transmission.","volume":"102","author":"Sansom","year":"2003","journal-title":"Obstet Gynecol"},{"key":"R14-23-20210202","first-page":"1","article-title":"U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women.","volume":"44","year":"1995","journal-title":"MMWR Recomm Rep"},{"key":"R15-23-20210202","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJM199807023390107","article-title":"Acute human immunodeficiency virus type 1 infection.","volume":"339","author":"Kahn","year":"1998","journal-title":"N Engl J Med"},{"key":"R16-23-20210202","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-134-1-200101020-00010","article-title":"Diagnosis of primary HIV-1 infection. Los Angeles County Primary HIV Infection Recruitment Network.","volume":"134","author":"Daar","year":"2001","journal-title":"Ann Intern Med"},{"key":"R17-23-20210202","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1086\/313718","article-title":"Primary human immunodeficiency virus type 1 infection: clinical manifestations among women in Mombasa, Kenya.","volume":"30","author":"Lavreys","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R18-23-20210202","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1542\/peds.112.4.e289","article-title":"Pediatric viral human immunodeficiency virus type 1 RNA levels, timing of infection, and disease progression in African HIV-1-infected children.","volume":"112","author":"Rouet","year":"2003","journal-title":"Pediatrics"},{"key":"R19-23-20210202","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1086\/515596","article-title":"Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group.","volume":"178","author":"Abrams","year":"1998","journal-title":"J Infect Dis"},{"key":"R20-23-20210202","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.4049\/jimmunol.174.12.8191","article-title":"Correlates of delayed disease progression in HIV-1-infected Kenyan children.","volume":"174","author":"Chakraborty","year":"2005","journal-title":"J Immunol"},{"key":"R21-23-20210202","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(03)14793-9","article-title":"Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis.","volume":"362","author":"Dunn","year":"2003","journal-title":"Lancet"},{"key":"R22-23-20210202","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1097\/00002030-200211220-00010","article-title":"Primary HIV-1 infection in African children infected through breastfeeding.","volume":"16","author":"Rouet","year":"2002","journal-title":"AIDS"},{"key":"R23-23-20210202","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1086\/431197","article-title":"HIV-1 proteases from drug-naive West African patients are differentially less susceptible to protease inhibitors.","volume":"41","author":"Kinomoto","year":"2005","journal-title":"Clin Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006454-200707000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T02:00:07Z","timestamp":1618279207000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-200707000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3180616ca5","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}